LYUDMILA REED: Open Payments
NPI 1831661347 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 17 payments from 4 companies in 2025. Trend: 2023 $640 · 2024 $1,945 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $163 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: CAPLYTA, UBRELVY, QULIPTA, CONTRAVE, XIFAXAN.
Industry payments across GA — which companies pay providers there.
